Pharmaceutical Records Incorporated  
 
    PRI Home    |     Services    |     Products    |     Contact Us
 

 

     New DEA Fee Schedules

      A new DEA fee schedule is in effect for all new registration applications postmarked on or after December 1, 2003

        and all re-registration applications postmarked on or after December 1, 2003.  This rulemaking also establishes   

        new annual registration /re-registration fee amounts for dispensers, including central fill pharmacies, and teaching

        institutions of $390 for a three-year period.  The annual registration and re-registration fee for researchers, narcotic

        treatment programs (including compounders), effective with this rulemaking, is $130.  These categories of

        registrants obtain a registration and pay the associated fee on an annual basis.

 

 

Business Activity

Controlled Substances

DEA Application Forms

Application Fee ($)

Registration Period (years)

 
 

  Manufacturing

Schedules I-V

New--225
Renewal--225a

1,625
1,625

1

 
 

  Distributing

Schedules I-V

New--225
Renewal--225a

813
813

1

 
 

  Reverse distributing

Schedules I-V

New--225
Renewal 225a

813
813

1

 
 

  Dispensing or instructing (includes  

  Practitioner, Hospital/ Clinic, Retail

  Pharmacy, Central Fill Pharmacy, Teaching

  Institution).

Schedules II-V

New--224
Renewal--224a

390
390

3

 
 

  Research

Schedule I

New--225
Renewal--225a

130
130

1

 
 

  Research

Schedules II-V

New--225
Renewal--225a

130
130

1

 
 

  Narcotic Treatment Program  (including

  compounders).

Narcotic Drugs in Schedules II-V

New--363
Renewal 363a

130
130

1

 
 

  Importing

Schedules I-V

New--225
Renewal--225a

813
813

1

 
 

  Exporting

Schedules I-V

New--225
Renewal--225a

813
813

1

 
 

  Chemical Analysis

Schedules I-V

New--225
Renewal--225a

130
130

1

 

 

 

 

 

 


 Contact Us |  DEA Compliance Newsletter |  Legal
 2004 Pharmaceutical Records Incorporated. All rights reserved. Terms of Use | Privacy Statement | Accessibility